Enoxacin gluconate China manufacture 98.5%min

Enoxacin

1,8-Naphthyridine-3-carboxylic acid,1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-;1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid;AT 2266;Enoxacin;Enoxacine;Flumark;Penetrex;Penetrex (pharmaceutical);Enoksetin;PD 107779;CI 919;NSC 629661;Enofloxacin;ENOXOR;Enofloxacine;1-Ethyl-6-fluoro-4-oxo-7-piperazin-4-ium-1-yl-1,8-naphthyridine-3-carboxylate;1-Ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid

74011-58-8

C15H17FN4O3

InChIKey=IDYZIJYBMGIQMJ-UHFFFAOYSA-N

320.32

320.32

1308068-626-2

325OGW249P

758416|629661

DTXSID5022984

J - Antiinfectives for systemic use

29335995

Synthetic Anti-infective Drugs

85.8

2.3

Solid

1.4±0.1 g/cm3

220-224 °C

569.9±50.0 °C at 760 mmHg

298.4±30.1 °C

1.599

H2O: 50 mg/ml in 1 M NaOHSlightly soluble in sodium hydroxide, dimethyl sulfoxide, chloroform and methanol. Insoluble in water.

2-8°C

LD50 in male, female mice, male, female rats (mg/kg): 327, 391, 236, 294 i.v.; 1237, 1320, >2000, >2000 s.c.; all >5000 orally (Senda)

168.1 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]|184.7 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]|170.8 Ų [M+H]+ [CCS Type: TW, Method: calibrated with Waters Major Mix]|185 Ų [M+Na]+ [CCS Type: TW, Method: calibrated with Waters Major Mix]